文献
J-GLOBAL ID:201902223859186737
整理番号:19A0694246
臨床環境における114癌関連遺伝子のパネル試験の実現可能性と有用性:病院ベース研究
Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: A hospital-based study
著者 (46件):
Sunami Kuniko
(Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan)
,
Ichikawa Hitoshi
(Department of Clinical Genomics, National Cancer Center Research Institute, Tokyo, Japan)
,
Ichikawa Hitoshi
(Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan)
,
Kubo Takashi
(Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan)
,
Kubo Takashi
(Department of Clinical Genomics, National Cancer Center Research Institute, Tokyo, Japan)
,
Kubo Takashi
(Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan)
,
Kato Mamoru
(Department of Bioinformatics, National Cancer Center Research Institute, Tokyo, Japan)
,
Fujiwara Yutaka
(Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan)
,
Shimomura Akihiko
(Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan)
,
Koyama Takafumi
(Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan)
,
Kakishima Hiroki
(Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan)
,
Kitami Mayuko
(Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan)
,
Matsushita Hiromichi
(Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan)
,
Furukawa Eisaku
(Department of Bioinformatics, National Cancer Center Research Institute, Tokyo, Japan)
,
Narushima Daichi
(Department of Bioinformatics, National Cancer Center Research Institute, Tokyo, Japan)
,
Nagai Momoko
(Department of Bioinformatics, National Cancer Center Research Institute, Tokyo, Japan)
,
Taniguchi Hirokazu
(Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan)
,
Motoi Noriko
(Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan)
,
Sekine Shigeki
(Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan)
,
Maeshima Akiko
(Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan)
,
Mori Taisuke
(Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan)
,
Watanabe Reiko
(Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan)
,
Yoshida Masayuki
(Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan)
,
Yoshida Akihiko
(Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan)
,
Yoshida Hiroshi
(Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan)
,
Satomi Kaishi
(Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan)
,
Sukeda Aoi
(Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan)
,
Hashimoto Taiki
(Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan)
,
Shimizu Toshio
(Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan)
,
Iwasa Satoru
(Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan)
,
Yonemori Kan
(Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan)
,
Kato Ken
(Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan)
,
Morizane Chigusa
(Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan)
,
Ogawa Chitose
(Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan)
,
Tanabe Noriko
(Genetic Medicine and Services, National Cancer Center Hospital, Tokyo, Japan)
,
Sugano Kokichi
(Genetic Medicine and Services, National Cancer Center Hospital, Tokyo, Japan)
,
Sugano Kokichi
(Oncogene Research Unit/Cancer Prevention Unit, Tochigi Cancer Center Research Institute, Tochigi, Japan)
,
Hiraoka Nobuyoshi
(Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan)
,
Tamura Kenji
(Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan)
,
Yoshida Teruhiko
(Genetic Medicine and Services, National Cancer Center Hospital, Tokyo, Japan)
,
Fujiwara Yasuhiro
(Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan)
,
Fujiwara Yasuhiro
(Strategic Planning Bureau, National Cancer Center, Tokyo, Japan)
,
Ochiai Atsushi
(Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan)
,
Yamamoto Noboru
(Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan)
,
Kohno Takashi
(Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan)
,
Kohno Takashi
(Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan)
資料名:
Cancer Science (Web)
(Cancer Science (Web))
巻:
110
号:
4
ページ:
1480-1490
発行年:
2019年
JST資料番号:
U0505A
ISSN:
1349-7006
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)